Bookmark Add to Calendar

Sunshine Act Reporting – Clarification for Clinical Research

Duration : 75 Minutes

Danielle DeLucy, Pharmaceuticals, Biotechnology

Danielle DeLucy, MS, is owner of ASA Training and Consulting, LLC which provides Pharmaceutical and Biologics based companies with training and quality systems assistance in order to meet Regulatory compliance. Prior to this role, Danielle has been in the industry for 15 years serving in numerous Quality Management Roles, suc Read more

This webinar will summarize the Sunshine Act or Open Payments Program requirements and provide practical solutions to most common situations that are prevalent and necessary between sponsors and investigators.

The Sunshine Act or Open Payments Program requires manufacturers of drugs, medical devices, and biologics that participate in U.S. federal health care programs to report certain clinical investigator payments and items of value given to physicians and teaching hospitals. This Act was part of a healthcare reform bill adopted in March 2010. It came about due to requests for increased transparency about the financial relationships between physicians and industry.

Why Should You Attend:

The Sunshine Act exposes the physicians and sponsors to new clinical trial reporting requirements and detail non-compliance to which would lead to hefty fines. Templates for reporting format, exemptions to reporting requirements, and timelines for compliance and enforcement will be discussed.

Course Outline:

Life science companies face the challenge of implementing the detailed reporting required by the Act as healthcare providers determine how to use their own data to anticipate public reporting of payments by life science companies to physicians and teaching hospitals.
This webinar will examine the implications of the Sunshine Act for healthcare providers and life science companies, and discuss practical steps they can take to implement the Act and prepare for transparency.

• Purpose of the Sunshine Act
• Who is required to report under the Sunshine Act?
• What is reported?
• Exclusions
• Tracking
• Penalties
• Useful links

What You Get:

• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points

Who Will Benefit:

• Manufacturers of FDA regulated products: Drug, Medical Device and Biotech Companies
• Clinical Trial Professionals such as Project Managers, CRAs, Medical Writers
• Senior Management for Companies developing new products for US market
• Regulatory Affairs Professionals
• People investing in FDA-regulated products intended for the US market

Please reach us at 1-888-844-8963 for any further assistance or if you wish to register


Refund / Cancellation policy

Get In Touch

Subject : Sunshine Act Reporting – Clarification for Clinical Research

Similar Trainings

(TMF)- Trial Master File: FDA Expectations from Sponsors and Sites
LIVE : Scheduled on 03-July-2024 :01:00 PM EDT
paypal payment Comodo

Copyright ©2024 Signup Training. All rights reserved.